“FCGBP Inhibits the Development of LSCC and Cisplatin Resistance through the PIGR JAK2 STAT3 Pathway”. Radiology and Oncology 60, no. 1 (March 26, 2026): 67–75. Accessed July 29, 2026. https://www.ojstest.computing.si/index.php/ro/article/view/4672.